Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation

MLA

Thirunavukkarasu Velusamy, et al. “Oncogenic Y641 Mutations in EZH2 Prevent Jak2/β-TrCP-Mediated Degradation.” Oncogene, vol. 34, Jan. 2014, pp. 445–54. EBSCOhost, https://doi.org/10.1038/onc.2013.571.

APA

Thirunavukkarasu Velusamy, Kojo S.J. Elenitoba-Johnson, Xiaofei Chen, Anagh A. Sahasrabuddhe, Fuzon Chung, & Megan S. Lim. (2014). Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation. Oncogene, 34, 445–454. https://doi.org/10.1038/onc.2013.571

Chicago

Thirunavukkarasu Velusamy, Kojo S.J. Elenitoba-Johnson, Xiaofei Chen, Anagh A. Sahasrabuddhe, Fuzon Chung, and Megan S. Lim. 2014. “Oncogenic Y641 Mutations in EZH2 Prevent Jak2/β-TrCP-Mediated Degradation.” Oncogene 34 (January): 445–54. doi:10.1038/onc.2013.571.